home / stock / ctso / ctso quote
Last: | $1.01 |
---|---|
Change Percent: | 0.98% |
Open: | $0.9 |
Close: | $1.01 |
High: | $1.01 |
Low: | $0.9 |
Volume: | 233,509 |
Last Trade Date Time: | 07/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.01 | $0.9 | $1.01 | $1.01 | $0.9 | 233,509 | 07-08-2024 |
$0.9089 | $0.86 | $0.9089 | $0.925 | $0.831 | 177,069 | 07-05-2024 |
$0.86 | $0.8599 | $0.86 | $0.8641 | $0.812 | 165,276 | 07-04-2024 |
$0.86 | $0.8599 | $0.86 | $0.8641 | $0.812 | 165,276 | 07-03-2024 |
$0.8218 | $0.74 | $0.8218 | $0.865 | $0.74 | 379,186 | 07-02-2024 |
$0.7 | $0.7144 | $0.7 | $0.79 | $0.7 | 78,580 | 07-01-2024 |
$0.703 | $0.77 | $0.703 | $0.788686 | $0.703 | 165,742 | 06-28-2024 |
$0.7725 | $0.82 | $0.7725 | $0.82 | $0.7611 | 63,492 | 06-27-2024 |
$0.78 | $0.76 | $0.78 | $0.8181 | $0.76 | 85,155 | 06-26-2024 |
$0.7673 | $0.77 | $0.7673 | $0.8181 | $0.76 | 115,334 | 06-25-2024 |
$0.7708 | $0.783 | $0.7708 | $0.82 | $0.76 | 97,183 | 06-24-2024 |
$0.8 | $0.78 | $0.8 | $0.826314 | $0.78 | 78,478 | 06-21-2024 |
$0.7908 | $0.76 | $0.7908 | $0.8399 | $0.76 | 157,769 | 06-20-2024 |
$0.753 | $0.86 | $0.753 | $0.86 | $0.75 | 243,643 | 06-19-2024 |
$0.753 | $0.86 | $0.753 | $0.86 | $0.75 | 243,643 | 06-18-2024 |
$0.8321 | $0.8393 | $0.8321 | $0.9 | $0.832 | 36,712 | 06-17-2024 |
$0.8412 | $0.88 | $0.8412 | $0.895 | $0.8368 | 91,093 | 06-14-2024 |
$0.8651 | $0.86 | $0.8651 | $0.8999 | $0.86 | 140,073 | 06-13-2024 |
$0.8601 | $0.899 | $0.8601 | $0.899 | $0.8547 | 110,297 | 06-12-2024 |
$0.899 | $0.88 | $0.899 | $0.9 | $0.88 | 64,646 | 06-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
CytoSorbents Corporation Company Name:
CTSO Stock Symbol:
NASDAQ Market:
CytoSorbents Corporation Website:
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that on...
PRINCETON, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the reg...
PRINCETON, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the lau...